Distributor inventory
Glimepiride 1 mg + Metformin Hydrochloride 500 mg (sustained release) + Voglibose 0.2 mg (tablet)
Type 2 diabetes mellitus in adults when blood sugar is not adequately controlled with diet, exercise and/or other oral antidiabetic medicines; helps control post-meal and fasting blood glucose.
Metformin reduces glucose production in the liver and improves insulin sensitivity. Glimepiride increases insulin release from the pancreas. Voglibose slows carbohydrate digestion/absorption in the gut, reducing post-meal blood sugar spikes.
Take by mouth as prescribed, usually once daily with the first main meal; swallow whole with water and do not crush/chew (SR tablet). Follow diet and exercise advice; monitor blood glucose regularly.
Common side effects of GLUCONORM VG 1 may include:
Risk of hypoglycaemia (especially with missed meals, excess exercise, alcohol, or with other antidiabetics); metformin-associated lactic acidosis is rare but serious—avoid/use caution in severe kidney disease, severe liver disease, dehydration, sepsis, hypoxia, or heavy alcohol use. Check renal function before and during therapy; temporarily stop metformin before/after iodinated contrast or major surgery as advised by doctor. Use caution in elderly and in patients with irregular eating habits; seek help for severe weakness, breathing difficulty, persistent vomiting, or confusion.
